• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 28, 2022 at 11:22: AM
via GV, Northpond Ventures and Sanofi Ventures have joined forces to pump $100 million into OMass Therapeutics, teeing the British biotech up to advance candidates against hard-to-hit targets toward the clinic.

article source
 




Top Bottom
Back
Quote